Global Proteomics Market Analysis

Executive Summary
Strong growth curves ahead for many market segments
• The US proteomics market benefits from the vast diversity and scale of
operations of the academic sector. Further, ability of academics to reposition
themselves into new groups in order to meet the scientific challenges in
proteomics industry also proves beneficial for the industry. Proteomics
research, being complementary to genomic approaches, has been
witnessing increased integration with drug discovery market. Rising interest
in integrated technologies is driving rapid expansion of bio-informatics and
protein biochip technologies in Europe.
• The shift towards proteomics from genomics facilitates technological
advancements, which are aimed at providing assistance to drug discovery
researchers by offering enhanced throughput, resolution, and sensitivity,
compared to conventional protein research tools.
• Over the next decade, better understanding of proteome will lead to the
development of advanced sequencing methods and superior technologies
that help expand application possibilities.
• Discovery of new biomarkers is expected to enable successful development
of newer drugs. Technological improvements in instruments and workflow
and miniaturization of biochip devices will create new milestones in diagnosis
and drug development applications. Biomarker-based research will be a
strong area of focus given the increasing importance of proteomics in novel
drug discovery, design, and development.
• Major players covered in the report include Bio-Rad Laboratories Inc.,
ThermoFisher Scientific, Waters Corporation, Sigma-Aldrich Corporation,
PerkinElmer Inc., Bruker Daltonics Inc., Caprion Proteomics Inc., GE
Healthcare, and Shimadzu Biotech, among others.
www.merkleandsears.com
U.S.
Canada
Mexico
Rest of
North
America
North American proteomics market
by application
Aggregate
2020 demand
Market share breakdown, 2015
xx%
xx%
xx
xx
xx
xx
Demand
growth
%, CAGR
xx
xx
xx
xx
xx
xx
xx
xx
xx%
3